Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT04511832
Eligibility Criteria:
Inclusion Criteria:
* Women who were postmenopausal aged more than 20 years old.
* history of stage 0 to III hormone receptor-positive breast cancer, and currently taking a third-generation AI (anastrozole, letrozole, or exemestane) for at least 3 month.
* Those who reported pain and/or stiffness in one or more joints, which started or worsened after initiation of AI therapy had worst joint pain rated at least three or greater on a 0-10 numerical rating scale in the preceding week.
Exclusion Criteria:
* any prior acupuncture use for AI-induced joint symptoms or acupuncture within 1 months before entry
* inflammatory, metabolic, or neuropathic arthropathies
* bone fracture/surgery of an afflicted extremity during the preceding 6 months
* allergy to NSAID
* current use of narcotics
* bleeding or coagulation disorders
* localized skin infections
* needle phobia
* intra-articular corticosteroid within 4 weeks preceding the study
* any severe chronic or uncontrolled comorbid disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT04511832
Study Brief:
Protocol Section:
NCT04511832